Abstract

Introduction

Older adults are at increased risks of drug-related problems, contributed by increasing incidence of multimorbidity with age, and the consequent polypharmacy. We aim to investigate the drug classes associated with 30-day readmissions in hospitalised older adults.

Method

We prospectively studied patients aged 65 years and above admitted to a general medical department in Sengkang General Hospital, Singapore, between October 2018 and January 2020. Medication lists were obtained from electronic medical records at admission. Unplanned readmission within 30 days of discharge was tracked through the hospital’s electronic health records. Medications were classified according to the World Health Organisation’s Anatomical Therapeutic Chemical classification system. Univariate logistic regression was performed for the association of drug classes with 30-day readmission.

Results

We recruited 1507 consecutive admissions with follow-up data. 30-day readmission occurred in 331 patients (22.0%). Greater length of stay, higher comorbidity burden, hospitalisation in the year preceding index admission, frailty and polypharmacy were more commonly observed among patients who were readmitted within 30 days of discharge. Admission diagnoses associated with 30-day readmission include infections, fluid overload, acute coronary events and constipation. Drg classes associated with a higher risk of 30-day readmission include drugs for acid-related disorder (OR = 1.62, 95%CI 1.27–2.07), drugs for constipation (OR = 1.96, 95%CI 1.41–2.73), antithrombotic agents (OR = 1.40, 95%CI 1.09–1.79), antianaemic preparations (OR = 2.22, 95%CI 1.68–2.91), cardiac therapy (OR = 1.70, 95%CI 1.23–2.34), diuretics (OR = 1.41, 95%CI 1.04–1.90), beta-blocking agents (OR = 1.55, 95%CI 1.21–1.99) and analgesics (OR = 1.56, 95%CI 1.02–2.39).

Conclusion

Drg classes associated with 30-day geriatric readmissions include drugs for acid-related disorder, constipation, antithrombotic agents, antianaemic preparations, cardiac therapy, diuretics, beta-blocking agents and analgesics. Patients on the above drug classes should herald a higher index of scrutiny during admissions and necessitate closer follow-up upon discharge.

This content is only available as a PDF.
This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://dbpia.nl.go.kr/pages/standard-publication-reuse-rights)
You do not currently have access to this article.

Comments

0 Comments
Submit a comment
You have entered an invalid code
Thank you for submitting a comment on this article. Your comment will be reviewed and published at the journal's discretion. Please check for further notifications by email.